{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T12:04:37Z","timestamp":1792497877089,"version":"4.5.0"},"reference-count":56,"publisher":"Elsevier BV","issue":"16","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,26]],"date-time":"2020-08-26T00:00:00Z","timestamp":1598400000000},"content-version":"vor","delay-in-days":1243,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 GM067871"],"award-info":[{"award-number":["R01 GM067871"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1074\/jbc.m117.778308","type":"journal-article","created":{"date-parts":[[2017,3,3]],"date-time":"2017-03-03T20:35:15Z","timestamp":1488573315000},"page":"6728-6743","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":433,"title":["Structural analyses of Candida albicans sterol 14\u03b1-demethylase complexed with azole drugs address the molecular basis of azole-mediated inhibition of fungal sterol biosynthesis"],"prefix":"10.1016","volume":"292","author":[{"given":"Tatiana Y.","family":"Hargrove","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Friggeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zdzislaw","family":"Wawrzak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aidong","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William J.","family":"Hoekstra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Schotzinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John D.","family":"York","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F. Peter","family":"Guengerich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Galina I.","family":"Lepesheva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1074\/jbc.M117.778308_bib1","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/nrmicro.2016.157","article-title":"Candida albicans cell-type switching and functional plasticity in the mammalian host","volume":"15","author":"Noble","year":"2017","journal-title":"Nat. Rev. Microbiol"},{"key":"10.1074\/jbc.M117.778308_bib2","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1056\/NEJMra1315399","article-title":"Invasive candidiasis","volume":"373","author":"Kullberg","year":"2015","journal-title":"N. Engl. J. Med"},{"key":"10.1074\/jbc.M117.778308_bib3","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.4155\/fmc-2016-0124","article-title":"How can we bolster the antifungal drug discovery pipeline?","volume":"8","author":"Jampilek","year":"2016","journal-title":"Future Med. Chem"},{"key":"10.1074\/jbc.M117.778308_bib4","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.mib.2016.08.006","article-title":"Cell biology of Candida albicans\u2013host interactions","volume":"34","author":"da Silva Dantas","year":"2016","journal-title":"Curr. Opin. Microbiol"},{"key":"10.1074\/jbc.M117.778308_bib5","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1111\/j.1462-5822.2012.01813.x","article-title":"Host carbon sources modulate cell wall architecture, drug resistance and virulence in a fungal pathogen","volume":"14","author":"Ene","year":"2012","journal-title":"Cell. Microbiol"},{"key":"10.1074\/jbc.M117.778308_bib6","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.MB-0005-2014","article-title":"Candida albicans biofilm development and its genetic control","volume":"3","author":"Desai","year":"2015","journal-title":"Microbiol. Spectr"},{"key":"10.1074\/jbc.M117.778308_bib7","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/civ933","article-title":"Clinical practice guideline for the management of candidiasis: 2016 Update by the Infectious Diseases Society of America","volume":"62","author":"Pappas","year":"2016","journal-title":"Clin. Infect. Dis"},{"key":"10.1074\/jbc.M117.778308_bib8","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2147\/TCRM.S40160","article-title":"Epidemiology and risk factors for invasive candidiasis","volume":"10","author":"Yapar","year":"2014","journal-title":"Ther. Clin. Risk Manag"},{"key":"10.1074\/jbc.M117.778308_bib9","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.2147\/TCRM.S90335","article-title":"Role of isavuconazole in the treatment of invasive fungal infections","volume":"12","author":"Wilson","year":"2016","journal-title":"Ther. Clin. Risk Manag"},{"key":"10.1074\/jbc.M117.778308_bib10","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ejim.2016.06.029","article-title":"Candidemia and invasive candidiasis in adults: a narrative review","volume":"34","author":"Antinori","year":"2016","journal-title":"Eur. J. Intern. Med"},{"key":"10.1074\/jbc.M117.778308_bib11","doi-asserted-by":"crossref","first-page":"165rv13","DOI":"10.1126\/scitranslmed.3004404","article-title":"Hidden killers: human fungal infections","volume":"4","author":"Brown","year":"2012","journal-title":"Sci. Transl. Med"},{"key":"10.1074\/jbc.M117.778308_bib12","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.2165\/11596540-000000000-00000","article-title":"Triazole antifungal agents in invasive fungal infections","volume":"71","author":"Lass-Fl\u00f6rl","year":"2011","journal-title":"Drugs"},{"key":"10.1074\/jbc.M117.778308_bib13","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1194\/jlr.M069229","article-title":"Human sterol 14\u03b1-demethylase as a target for anticancer chemotherapy: towards structure-aided drug design","volume":"57","author":"Hargrove","year":"2016","journal-title":"J. Lipid Res"},{"key":"10.1074\/jbc.M117.778308_bib14","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1093\/jac\/12.4.303","article-title":"Effect of imidazole antifungals on the development of germ tubes by strains of Candida albicans","volume":"12","author":"Johnson","year":"1983","journal-title":"J. Antimicrob. Chemother"},{"key":"10.1074\/jbc.M117.778308_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/AAC.32.1.1","article-title":"Azole antifungal agents: emphasis on new triazoles","volume":"32","author":"Saag","year":"1988","journal-title":"Antimicrob. Agents Chemother"},{"key":"10.1074\/jbc.M117.778308_bib16","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1086\/596757","article-title":"Clinical practice guidelines for the management candidiasis: 2009 update by the Infectious Diseases Society of America","volume":"48","author":"Pappas","year":"2009","journal-title":"Clin. Infect. Dis"},{"key":"10.1074\/jbc.M117.778308_bib17","doi-asserted-by":"crossref","first-page":"3540","DOI":"10.1093\/jac\/dkw322","article-title":"Safety, clinical effectiveness and trough plasma concentrations of intravenous posaconazole in patients with haematological malignancies and\/or undergoing allogeneic haematopoietic stem cell transplantation: off-trial experience","volume":"71","author":"Jeong","year":"2016","journal-title":"J. Antimicrob. Chemother"},{"key":"10.1074\/jbc.M117.778308_bib18","series-title":"Sterol Biosynthesis Inhibitors","first-page":"79","author":"van den Bossche","year":"1988"},{"key":"10.1074\/jbc.M117.778308_bib19","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.bbagen.2006.07.018","article-title":"Sterol 14\u03b1-demethylase cytochrome P450 (CYP51), a P450 in all biological kingdoms","volume":"1770","author":"Lepesheva","year":"2007","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1074\/jbc.M117.778308_bib20","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.bbapap.2010.06.006","article-title":"Structural basis for conservation in the CYP51 family","volume":"1814","author":"Lepesheva","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1074\/jbc.M117.778308_bib21","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1194\/jlr.M021865","article-title":"Structural complex of sterol 14\u03b1-demethylase (CYP51) with 14\u03b1-methylenecyclopropyl-\u03947\u201324,25-dihydrolanosterol","volume":"53","author":"Hargrove","year":"2012","journal-title":"J. Lipid Res"},{"key":"10.1074\/jbc.M117.778308_bib22","series-title":"Cytochrome P450: Structure, Mechanism, and Biochemistry","first-page":"246","author":"Correia","year":"2005"},{"key":"10.1074\/jbc.M117.778308_bib23","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.chembiol.2007.10.011","article-title":"Sterol 14\u03b1-demethylase as a potential target for antitrypanosomal therapy: enzyme inhibition and parasite cell growth","volume":"14","author":"Lepesheva","year":"2007","journal-title":"Chem. Biol"},{"key":"10.1074\/jbc.M117.778308_bib24","doi-asserted-by":"crossref","first-page":"25582","DOI":"10.1074\/jbc.M110.133215","article-title":"Structural insights into inhibition of sterol 14 \u03b1-demethylase in the human pathogen Trypanosoma cruzi","volume":"285","author":"Lepesheva","year":"2010","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M117.778308_bib25","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1124\/dmd.30.3.314","article-title":"Inhibition of cytochromes P450 by antifungal imidazole derivatives","volume":"30","author":"Zhang","year":"2002","journal-title":"Drug Metab. Dispos"},{"key":"10.1074\/jbc.M117.778308_bib26","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1128\/CMR.11.2.382","article-title":"Clinical, cellular, and molecular factors that contribute to antifungal drug resistance","volume":"11","author":"White","year":"1998","journal-title":"Clin. Microbiol. Rev"},{"key":"10.1074\/jbc.M117.778308_bib27","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1126\/science.aaa6097","article-title":"How to bolster the antifungal pipeline","volume":"347","author":"Denning","year":"2015","journal-title":"Science"},{"key":"10.1074\/jbc.M117.778308_bib28","doi-asserted-by":"crossref","first-page":"3455","DOI":"10.1016\/j.bmcl.2014.05.068","article-title":"Design and optimization of highly-selective fungal CYP51 inhibitors","volume":"24","author":"Hoekstra","year":"2014","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1074\/jbc.M117.778308_bib29","doi-asserted-by":"crossref","first-page":"5567","DOI":"10.1128\/AAC.00185-15","article-title":"Efficacy of the clinical agent VT-1161 against fluconazole-sensitive and -resistant Candida albicans in a murine model of vaginal candidiasis","volume":"59","author":"Garvey","year":"2015","journal-title":"Antimicrob. Agents Chemother"},{"key":"10.1074\/jbc.M117.778308_bib30","doi-asserted-by":"crossref","first-page":"23916","DOI":"10.1074\/jbc.M115.677310","article-title":"Structure-functional characterization of cytochrome P450 sterol 14\u03b1-demethylase (CYP51B) from Aspergillus fumigatus and molecular basis for the development of antifungal drugs","volume":"290","author":"Hargrove","year":"2015","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M117.778308_bib31","doi-asserted-by":"crossref","first-page":"3878","DOI":"10.1016\/j.febslet.2014.08.030","article-title":"Sequence variation in CYP51A from the Y strain of Trypanosoma cruzi alters its sensitivity to inhibition","volume":"588","author":"Cherkesova","year":"2014","journal-title":"FEBS Lett"},{"key":"10.1074\/jbc.M117.778308_bib32","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1126\/science.1585174","article-title":"The early evolution of eukaryotes: a geological perspective","volume":"256","author":"Knoll","year":"1992","journal-title":"Science"},{"key":"10.1074\/jbc.M117.778308_bib33","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1126\/science.1061457","article-title":"Molecular evidence for the early colonization of land by fungi and plants","volume":"293","author":"Heckman","year":"2001","journal-title":"Science"},{"key":"10.1074\/jbc.M117.778308_bib34","doi-asserted-by":"crossref","first-page":"28413","DOI":"10.1074\/jbc.M102767200","article-title":"Folding requirements are different between sterol 14\u03b1-demethylase (CYP51) from Mycobacterium tuberculosis and human or fungal orthologs","volume":"276","author":"Lepesheva","year":"2001","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M117.778308_bib35","doi-asserted-by":"crossref","first-page":"10789","DOI":"10.1021\/bi048967t","article-title":"CYP51 from Trypanosoma brucei is obtusifoliol-specific","volume":"43","author":"Lepesheva","year":"2004","journal-title":"Biochemistry"},{"key":"10.1074\/jbc.M117.778308_bib36","doi-asserted-by":"crossref","first-page":"3577","DOI":"10.1074\/jbc.M510317200","article-title":"CYP51 from Trypanosoma cruzi: a phyla-specific residue in the B\u2032 helix defines substrate preferences of sterol 14\u03b1-demethylase","volume":"281","author":"Lepesheva","year":"2006","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M117.778308_bib37","doi-asserted-by":"crossref","first-page":"26838","DOI":"10.1074\/jbc.M111.237099","article-title":"Substrate preferences and catalytic parameters determined by structural characteristics of sterol 14\u03b1-demethylase (CYP51) from Leishmania infantum","volume":"286","author":"Hargrove","year":"2011","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M117.778308_bib38","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1128\/AAC.02287-15","article-title":"Clinical candidate VT-1161's antiparasitic effect in vitro, activity in a murine model of Chagas disease, and structural characterization in complex with the target enzyme CYP51 from Trypanosoma cruzi","volume":"60","author":"Hoekstra","year":"2016","journal-title":"Antimicrob. Agents Chemother"},{"key":"10.1074\/jbc.M117.778308_bib39","doi-asserted-by":"crossref","first-page":"31602","DOI":"10.1074\/jbc.M113.497990","article-title":"Complexes of Trypanosoma cruzi sterol 14\u03b1-demethylase (CYP51) with two pyridine-based drug candidates for Chagas disease: Structural basis for pathogen selectivity","volume":"288","author":"Hargrove","year":"2013","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M117.778308_bib40","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1074\/jbc.M109.067470","article-title":"Crystal structures of Trypanosoma brucei sterol 14\u03b1-demethylase and implications for selective treatment of human infections","volume":"285","author":"Lepesheva","year":"2010","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M117.778308_bib41","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1093\/infdis\/jiv228","article-title":"VFV as a new effective CYP51 structure-derived drug candidate for Chagas disease and visceral leishmaniasis","volume":"212","author":"Lepesheva","year":"2015","journal-title":"J. Infect. Dis"},{"key":"10.1074\/jbc.M117.778308_bib42","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1021\/jm400012e","article-title":"Antitrypanosomal lead discovery: identification of a ligand-efficient inhibitor of Trypanosoma cruzi CYP51 and parasite growth","volume":"56","author":"Andriani","year":"2013","journal-title":"J. Med. Chem"},{"key":"10.1074\/jbc.M117.778308_bib43","doi-asserted-by":"crossref","first-page":"6704","DOI":"10.1021\/jm500739f","article-title":"Structural basis for rational design of inhibitors targeting Trypanosoma cruzi sterol 14\u03b1-demethylase: two regions of the enzyme molecule potentiate its inhibition","volume":"57","author":"Friggeri","year":"2014","journal-title":"J. Med. Chem"},{"key":"10.1074\/jbc.M117.778308_bib44","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0021-9258(18)48462-1","article-title":"Substrate recognition sites in cytochrome P450 family 2 (CYP2) proteins inferred from comparative analyses of amino acid and coding nucleotide sequences","volume":"267","author":"Gotoh","year":"1992","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M117.778308_bib45","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/myc.12439","article-title":"Molecular mechanisms associated with fluconazole resistance in clinical Candida albicans isolates from India","volume":"59","author":"Mane","year":"2016","journal-title":"Mycoses"},{"key":"10.1074\/jbc.M117.778308_bib46","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.diagmicrobio.2009.11.006","article-title":"Screening for amino acid substitutions in the Candida albicans Erg11 protein of azole-susceptible and azole-resistant clinical isolates: new substitutions and a review of the literature","volume":"66","author":"Morio","year":"2010","journal-title":"Diagn. Microbiol. Infect. Dis"},{"key":"10.1074\/jbc.M117.778308_bib47","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1099\/00221287-145-10-2701","article-title":"Contribution of mutations in the cytochrome P450 14\u03b1-demethylase (Erg11p, Cyp51p) to azole resistance in Candida albicans","volume":"145","author":"Marichal","year":"1999","journal-title":"Microbiology"},{"key":"10.1074\/jbc.M117.778308_bib48","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1007\/s12275-016-5628-4","article-title":"The development of fluconazole resistance in Candida albicans\u2013an example of microevolution of a fungal pathogen","volume":"54","author":"Morschh\u00e4user","year":"2016","journal-title":"J. Microbiol"},{"key":"10.1074\/jbc.M117.778308_bib49","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S1471-4914(02)02280-3","article-title":"Molecular basis of resistance to azole antifungals","volume":"8","author":"Lupetti","year":"2002","journal-title":"Trends Mol. Med"},{"key":"10.1074\/jbc.M117.778308_bib50","doi-asserted-by":"crossref","first-page":"e01817","DOI":"10.1128\/AAC.01817-16","article-title":"Fungal CYP51 inhibitors VT-1161 and VT-1129 exhibit strong in vitro activity against Candida glabrata and C. krusei isolates clinically resistant to azole and echinocandin antifungal compounds","volume":"61","author":"Schell","year":"2017","journal-title":"Antimicrob. Agents Chemother"},{"key":"10.1074\/jbc.M117.778308_bib51","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0167-4838(99)00156-9","article-title":"Conformational dynamics and molecular interaction reactions of recombinant cytochrome P450scc (CYP11A1) detected by fluorescence energy transfer","volume":"1434","author":"Lepesheva","year":"1999","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1074\/jbc.M117.778308_bib52","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1107\/S0907444903008126","article-title":"A graphical user interface to the CCP4 program suite","volume":"59","author":"Potterton","year":"2003","journal-title":"Acta Crystallogr. D Biol. Crystallogr"},{"key":"10.1074\/jbc.M117.778308_bib53","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1107\/S0907444910007493","article-title":"Features and development of Coot","volume":"66","author":"Emsley","year":"2010","journal-title":"Acta Crystallogr. D Biol. Crystallogr"},{"key":"10.1074\/jbc.M117.778308_bib54","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1107\/S0907444904026460","article-title":"Secondary-structure matching (SSM), a new tool for fast protein structure alignment in three dimensions","volume":"60","author":"Krissinel","year":"2004","journal-title":"Acta Crystallogr. D Biol. Crystallogr"},{"key":"10.1074\/jbc.M117.778308_bib55","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF Chimera\u2014A visualization system for exploratory research and analysis","volume":"25","author":"Pettersen","year":"2004","journal-title":"J. Comput. Chem"},{"key":"10.1074\/jbc.M117.778308_bib56","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1126\/science.287.5458.1615","article-title":"The catalytic pathway of cytochrome P450cam at atomic resolution","volume":"287","author":"Schlichting","year":"2000","journal-title":"Science"}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820365868?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820365868?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1074\/jbc.M117.778308","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,4]],"date-time":"2022-01-04T03:05:24Z","timestamp":1641265524000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925820365868"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":56,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["S0021925820365868"],"URL":"https:\/\/doi.org\/10.1074\/jbc.m117.778308","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Structural analyses of Candida albicans sterol 14\u03b1-demethylase complexed with azole drugs address the molecular basis of azole-mediated inhibition of fungal sterol biosynthesis","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1074\/jbc.M117.778308","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 ASBMB. Currently published by Elsevier Inc; originally published by American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}]}}